scholarly journals Conditional Knockout of the RNA-Binding Protein HuR in CD4+ T Cells Reveals a Gene Dosage Effect on Cytokine Production

2014 ◽  
Vol 20 (1) ◽  
pp. 93-108 ◽  
Author(s):  
Matthew M. Gubin ◽  
Patsharaporn Techasintana ◽  
Joseph D. Magee ◽  
Garrett M. Dahm ◽  
Robert Calaluce ◽  
...  
2006 ◽  
Vol 177 (7) ◽  
pp. 4426-4435 ◽  
Author(s):  
Timur O. Yarovinsky ◽  
Noah S. Butler ◽  
Martha M. Monick ◽  
Gary W. Hunninghake

2014 ◽  
Vol 133 (2) ◽  
pp. AB399
Author(s):  
Ulus Atasoy ◽  
Patsharaporn Techasintana ◽  
Joseph Magee ◽  
Matt Gubin ◽  
Joe Rowles

2007 ◽  
Vol &NA; ◽  
pp. S35
Author(s):  
Cristiana Stellato ◽  
J Fang ◽  
B Tancowny ◽  
J Fan ◽  
F Wu ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Sohei Makita ◽  
Hiroaki Takatori ◽  
Arifumi Iwata ◽  
Shigeru Tanaka ◽  
Shunsuke Furuta ◽  
...  

2019 ◽  
Author(s):  
Ephraim Abrokwa Ansa-Addo ◽  
Huai-Cheng Huang ◽  
Brian Riesenberg ◽  
Supinya Iamsawat ◽  
Davis Borucki ◽  
...  

2007 ◽  
Vol 119 (1) ◽  
pp. S133
Author(s):  
C. Stellato ◽  
X. Fang ◽  
B. Tancowny ◽  
J. Fan ◽  
F. Wu ◽  
...  

2019 ◽  
Vol 20 (5) ◽  
pp. 1010 ◽  
Author(s):  
Yoshika Hayakawa-Yano ◽  
Masato Yano

A set of tissue-specific splicing factors are thought to govern alternative splicing events during neural progenitor cell (NPC)-to-neuron transition by regulating neuron-specific exons. Here, we propose one such factor, RNA-binding protein Quaking 5 (Qki5), which is specifically expressed in the early embryonic neural stem cells. We performed mRNA-SEQ (Sequence) analysis using mRNAs obtained by developing cerebral cortices in Qk (Quaking) conditional knockout (cKO) mice. As expected, we found a large number of alternative splicing changes between control and conditional knockouts relative to changes in transcript levels. DAVID (The Database for Annotation, Visualization and Integrated Discovery) and Metascape analyses suggested that the affected spliced genes are involved in axon development and microtubule-based processes. Among these, the mRNA coding for the Ninein protein is listed as one of Qki protein-dependent alternative splicing targets. Interestingly, this exon encodes a very long polypeptide (2121 nt), and has been previously defined as a dynamic RNA switch during the NPC-to-neuron transition. Additionally, we validated that the regulation of this large exon is consistent with the Qki5-dependent alternative exon inclusion mode suggested by our previous Qki5 HITS-CLIP (high throughput sequencing-cross linking immunoprecipitation) analysis. Taken together, these data suggest that Qki5 is an important factor for alternative splicing in the NPC-to-neuron transition.


mBio ◽  
2019 ◽  
Vol 10 (5) ◽  
Author(s):  
Ti-Chun Chao ◽  
Qiong Zhang ◽  
Zhonghan Li ◽  
Shashi Kant Tiwari ◽  
Yue Qin ◽  
...  

ABSTRACT A major challenge in finding a cure for HIV-1/AIDS is the difficulty in identifying and eradicating persistent reservoirs of replication-competent provirus. Long noncoding RNAs (lncRNAs, >200 nucleotides) are increasingly recognized to play important roles in pathophysiology. Here, we report the first genome-wide expression analysis of lncRNAs in HIV-1-infected primary monocyte-derived macrophages (MDMs). We identified an lncRNA, which we named HIV-1-enhanced lncRNA (HEAL), that is upregulated by HIV-1 infection of MDMs, microglia, and T lymphocytes. Peripheral blood mononuclear cells of HIV-1-infected individuals show elevated levels of HEAL. Importantly, HEAL is a broad enhancer of multiple HIV-1 strains because depletion of HEAL inhibited X4, R5, and dual-tropic HIV replications and the inhibition was rescued by HEAL overexpression. HEAL forms a complex with the RNA-binding protein FUS, which facilitates HIV replication through at least two mechanisms: (i) HEAL-FUS complex binds the HIV promoter and enhances recruitment of the histone acetyltransferase p300, which positively regulates HIV transcription by increasing histone H3K27 acetylation and P-TEFb enrichment on the HIV promoter, and (ii) HEAL-FUS complex is enriched at the promoter of the cyclin-dependent kinase 2 gene, CDK2, to enhance CDK2 expression. Notably, HEAL knockdown and knockout mediated by RNA interference (RNAi) and CRISPR-Cas9, respectively, prevent HIV-1 recrudescence in T cells and microglia upon cessation of azidothymidine treatment in vitro. Our results suggest that silencing of HEAL or perturbation of the HEAL-FUS ribonucleoprotein complex could provide a new epigenetic silencing strategy to eradicate viral reservoirs and effect a cure for HIV-1/AIDS. IMPORTANCE Despite our increased understanding of the functions of lncRNAs, their potential to develop HIV/AIDS cure strategies remains unexplored. A genome-wide analysis of lncRNAs in HIV-1-infected primary monocyte-derived macrophages (MDMs) was performed, and 1,145 differentially expressed lncRNAs were identified. An lncRNA named HIV-1-enhanced lncRNA (HEAL) is upregulated by HIV-1 infection and promotes HIV replication in T cells and macrophages. HEAL forms a complex with the RNA-binding protein FUS to enhance transcriptional coactivator p300 recruitment to the HIV promoter. Furthermore, HEAL knockdown and knockout prevent HIV-1 recrudescence in T cells and microglia upon cessation of azidothymidine treatment, suggesting HEAL as a potential therapeutic target to cure HIV-1/AIDS.


2008 ◽  
Vol 121 (4) ◽  
pp. 853-859.e4 ◽  
Author(s):  
Vincenzo Casolaro ◽  
Xi Fang ◽  
Brian Tancowny ◽  
Jinshui Fan ◽  
Fan Wu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document